The outcomes that the Fund seeks to provide may only be realized if you are holding shares on the first day of the Outcome Period and continue to hold them on the last day of the Outcome Period. 0.79% expense ratio, $113M AUM, 6 holdings, inception 2026.
The outcomes that the Fund seeks to provide may only be realized if you are holding shares on the first day of the Outcome Period and continue to hold them on the last day of the Outcome Period. 0.79% expense ratio, $113M AUM, 6 holdings, inception 2026.
ETF Overview
The outcomes that the Fund seeks to provide may only be realized if you are holding shares on the first day of the Outcome Period and continue to hold them on the last day of the Outcome Period. There is no guarantee that the Outcomes for an Outcome Period will be realized or that the Fund will achieve its investment objective.
The outcomes that the Fund seeks to provide may only be realized if you are holding shares on the first day of the Outcome Period and continue to hold them on the last day of the Outcome Period. There is no guarantee that the Outcomes for an Outcome Period will be realized or that the Fund will achieve its investment objective. Innovator Equity Dual Directional 15 Buffer ETF provides exposure to the equity market. The portfolio is concentrated with 6 holdings. Sector allocation is spread across 11 sectors, with Technology as the largest at 33.1%.
Risk Metrics
Innovator Equity Dual Directional 15 Buffer ETF holds only 6 positions, creating elevated concentration risk where poor performance from a few holdings can significantly impact returns. A beta of 0.00 indicates lower volatility relative to the broader market. The 0.79% expense ratio is above average and will reduce net returns over time.
<a href="/etf/xbap">Innovator U.S. Equity Accelerated 9 Buffer ETF (XBAP)</a> (Equity) — 0.79% expense ratio
<a href="/etf/pjan">Innovator U.S. Equity Power Buffer ETF (PJAN)</a> (Equity) — 0.79% expense ratio
<a href="/etf/tbjl">Innovator 20+ Year Treasury Bond 9 Buffer ETF (TBJL)</a> (Equity) — 0.79% expense ratio
<a href="/etf/eapr">Innovator Emerging Markets Power Buffer ETF (EAPR)</a> (Equity) — 0.89% expense ratio
<a href="/etf/isep">Innovator Intl Developed Power Buffer ETF (ISEP)</a> (Equity) — 0.85% expense ratio
<a href="/etf/bsep">Innovator U.S. Equity Buffer ETF (BSEP)</a> (Equity) — 0.79% expense ratio
Risk Metrics
Beta: 0.00
Questions & Answers
What is Innovator Equity Dual Directional 15 Buffer ETF (DDFJ)?
The outcomes that the Fund seeks to provide may only be realized if you are holding shares on the first day of the Outcome Period and continue to hold them on the last day of the Outcome Period. There is no guarantee that the Outcomes for an Outcome It holds 6 securities. With $113M in assets under management, it is a funds in its category.
What is the expense ratio for DDFJ?
Innovator Equity Dual Directional 15 Buffer ETF has an expense ratio of 0.79%, which is considered higher than average for equity ETFs. This means for every $10,000 invested, annual fees would be approximately $79. Lower expense ratios generally lead to better long-term returns, all else being equal.
What sectors does DDFJ invest in?
Innovator Equity Dual Directional 15 Buffer ETF allocates across 11 sectors. The largest sector exposures are Technology (33.1%), Financial Services (12.3%), Communication Services (10.7%). The sector allocation provides broad market exposure across multiple industries.
What is the current NAV of DDFJ?
Innovator Equity Dual Directional 15 Buffer ETF has a net asset value (NAV) of approximately $18.84 per share. The NAV represents the per-share value of the fund's underlying assets minus liabilities. Market price may differ slightly from NAV due to supply and demand dynamics during trading hours.
Is DDFJ a good investment?
Innovator Equity Dual Directional 15 Buffer ETF is a equity ETF with $113M in assets and 6 holdings. Equity ETFs are subject to market risk and can experience significant short-term volatility, though they have historically provided strong long-term returns for patient investors. Whether it is suitable depends on your investment goals, risk tolerance, and time horizon. Consider consulting a financial advisor for personalized guidance.